Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.
Romero AI, Lagging M, Westin J, Dhillon AP, Dustin LB, Pawlotsky JM, Neumann AU, Ferrari C, Missale G, Haagmans BL, Schalm SW, Zeuzem S, Negro F, Verheij-Hart E, Hellstrand K; DITTO-HCV Study Group. Romero AI, et al. Among authors: pawlotsky jm. J Infect Dis. 2006 Oct 1;194(7):895-903. doi: 10.1086/507307. Epub 2006 Aug 29. J Infect Dis. 2006. PMID: 16960776 Clinical Trial.
Hepatitis C virus in dermatology. A review.
Pawlotsky JM, Dhumeaux D, Bagot M. Pawlotsky JM, et al. Arch Dermatol. 1995 Oct;131(10):1185-93. Arch Dermatol. 1995. PMID: 7574837 Review.
Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
Pawlotsky JM, Hovanessian AG, Roudot-Thoraval F, Robert N, Bouvier M, Babany G, Duval J, Dhumeaux D. Pawlotsky JM, et al. Antimicrob Agents Chemother. 1996 Feb;40(2):320-4. doi: 10.1128/AAC.40.2.320. Antimicrob Agents Chemother. 1996. PMID: 8834873 Free PMC article.
GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
Pawlotsky JM, Roudot-Thoraval F, Muerhoff AS, Pellerin M, Germanidis G, Desai SM, Bastie A, Darthuy F, Rémiré J, Zafrani ES, Soussy CJ, Mushahwar IK, Dhumeaux D. Pawlotsky JM, et al. J Med Virol. 1998 Jan;54(1):26-37. doi: 10.1002/(sici)1096-9071(199801)54:1<26::aid-jmv5>3.0.co;2-r. J Med Virol. 1998. PMID: 9443106
506 results